Irene A Malaty

Dr. Irene A Malaty

orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 June 2018 in Science
Verified
Journal Article
Open access
PDF file
TCThe Brainstorm Consortium
The Brainstorm Consortium
VAVerneri Anttila
Verneri Anttila
BBBrendan Bulik-Sullivan
Brendan Bulik-Sullivan
HFHilary K. Finucane
Hilary K. Finucane
RWRaymond K. Walters
Raymond K. Walters
BNBenjamin M. Neale
Benjamin M. Neale
Brainstorming diseases: Consistent classification of neuropsychiatric diseases is problematic because it can lead to misunderstanding of etiology. The Brainstorm Consortium examined multiple genome-wide association studies drawn from more than 200,000 patients for 25 brain-associated disorders and 17 phenotypes. Broadly, it appears that psychiatric and neurologic disorders share relatively little common genetic risk. However, different and independent pathways can result in similar clinical manifestations (e.g., psychosis, which occurs in both schizophrenia and Alzheimer's disease). Schizophrenia correlated with many psychiatric disorders, whereas the immunopathological affliction Crohn's disease did not, and posttraumatic stress syndrome was also largely independent of underlying traits. Essentially, the earlier the onset of a disorder, the more inheritable it appeared to be. Science , this issue p. eaap8757

1 December 2019 in Cell
Verified
Journal Article
Closed access
PLPhil H. Lee
Phil H. Lee
VAVerneri Anttila
Verneri Anttila
HWHyejung Won
Hyejung Won
YFYen-Chen A. Feng
Yen-Chen A. Feng
JRJacob Rosenthal
Jacob Rosenthal
JSJordan Smoller
Jordan Smoller

1 March 2019 in American Journal of Psychiatry
Verified
Journal Article
Closed access
DYDongmei Yu
Dongmei Yu
JSJae Hoon Sul
Jae Hoon Sul
FTFotis Tsetsos
Fotis Tsetsos
MNMuhammad S. Nawaz
Muhammad S. Nawaz
AHAlden Y. Huang
Alden Y. Huang
TGthe Psychiatric Genomics Consortium Tourette Syndrome Working Group
the Psychiatric Genomics Consortium Tourette Syndrome Working Group

1 March 2018 in JAMA Neurology
Verified
Journal Article
Open access
PDF file
DMDaniel Martinez-Ramirez
Daniel Martinez-Ramirez
JJJoohi Jimenez-Shahed
Joohi Jimenez-Shahed
JLJames Frederick Leckman
James Frederick Leckman
MPMauro Porta
Mauro Porta
DSDomenico Servello
Domenico Servello
MOMichael S. Okun
Michael S. Okun
Surgical therapies for Tourette syndrome have been used since the early 1960s. Ablative procedures were initially used to target specific areas of the brain; these approaches revealed inconsistent, but in many cases reasonably positive, clinical outcomes, particularly on motor tics. Ablative surgical procedures did not become mainstream and largely disappeared from the treatment arsenal for Tourette syndrome.1 Deep brain stimulation (DBS) for Tourette syndrome, introduced in 1999,2 is a surgical therapy that uses an implantable device to deliver electrical stimulation to specific and carefully targeted brain structures. Deep brain stimulation is approved by the US Food and Drug Administration and Conformité Européene Mark approved in the European Union for the treatment of selected cases of Parkinson disease and essential tremor. Deep brain stimulation has a Conformité Européene Mark for selected cases of primary and secondary dystonia.3 Deep brain stimulation also received approval from the US Food and Drug Administration under a humanitarian device exemption for dystonia and obsessive-compulsive disorder.4 Although DBS is not approved for Tourette syndrome in the United States and other countries, multiple single reports and case series have collectively demonstrated that DBS could be a potentially valuable therapy for select cases of severe medication-resistant Tourette syndrome. A recent systematic review and meta-analysis of 57 studies including 156 cases of DBS for Tourette syndrome reported an overall improvement of 53% as measured by the total Yale Global Tic Severity Scale (YGTSS) score.5

1 May 2017 in Neuron
Verified
Journal Article
Closed access
AWA. Jeremy Willsey
A. Jeremy Willsey
TFThomas V. Fernandez
Thomas V. Fernandez
DYDongmei Yu
Dongmei Yu
RKRobert A. King
Robert A. King
ADAndrea Dietrich
Andrea Dietrich
JSJae-Hoon Sul
Jae-Hoon Sul

1 June 2017 in Neuron
Verified
Journal Article
Closed access
AHAlden Y. Huang
Alden Y. Huang
DYDongmei Yu
Dongmei Yu
LDLea K. Davis
Lea K. Davis
JSJae Hoon Sul
Jae Hoon Sul
FTFotis Tsetsos
Fotis Tsetsos
JSJan Smit
Jan Smit